Opioid Addiction Treatment Programs Enhancement Act
The source supplies the latest action, but no lifecycle stage.
Latest action (22 May 2018): Read twice and referred to the Committee on Finance.
What this bill does
The Opioid Addiction Treatment Programs Enhancement Act would require the Centers for Medicare & Medicaid Services (CMS) to publish an annual report detailing substance use disorders and their treatment within the Medicaid population. This report would include the number of diagnoses, types of treatment received, and how individuals accessed care through different Medicaid programs, such as managed care or fee-for-service. The data would be made available for all states and U.S. territories.
This bill primarily affects individuals enrolled in Medicaid who have substance use disorders and the healthcare providers who treat them. By providing comprehensive data, it aims to offer researchers and states a clearer understanding of the scope of the issue and the effectiveness of different treatment approaches.
Introduced in the Senate in May 2018, this bill has been referred to the Committee on Finance. No further action has been taken since its introduction. If enacted, the Secretary of Health and Human Services would be required to publish the first report within 12 months.
Plain-English summary generated by Bill100 AI from the official record. Always verify against the source below.
Official summary
Opioid Addiction Treatment Programs Enhancement Act
This bill requires the Centers for Medicare & Medicaid Services (CMS) to publish annually a report on the prevalence of substance use disorders and associated treatment within the Medicaid population in each state and U.S. territory. The report must include the number of substance use disorder diagnoses and the types of treatment received. The CMS must use specified data to compile the report and must make the data available to researchers and states.
Timeline
22 May 2018
Read twice and referred to the Committee on Finance.
Common questions
- What does S. 2912 do?
- The Opioid Addiction Treatment Programs Enhancement Act would require the Centers for Medicare & Medicaid Services (CMS) to publish an annual report detailing substance use disorders and their treatment within the Medicaid population. This report would include the number of diagnoses, types of treatment received, and how individuals accessed care through different Medicaid programs, such as managed care or fee-for-service. The data would be made available for all states and U.S. territories. This bill primarily affects individuals enrolled in Medicaid who have substance use disorders and the healthcare providers who treat them. By providing comprehensive data, it aims to offer researchers and states a clearer understanding of the scope of the issue and the effectiveness of different treatment approaches. Introduced in the Senate in May 2018, this bill has been referred to the Committee on Finance. No further action has been taken since its introduction. If enacted, the Secretary of Health and Human Services would be required to publish the first report within 12 months.
- Has S. 2912 become law?
- The source does not supply a confirmed lifecycle stage for S. 2912. Check the latest action and official source below.
- Who sponsored S. 2912?
- S. 2912 was sponsored by Sen. Cassidy, Bill [R-LA] (R-LA), with 4 cosponsors.
- What's the latest action on S. 2912?
- Read twice and referred to the Committee on Finance. (22 May 2018).
Related bills in Health
Choices for Increased Mobility Act of 2026
Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026
Access to Medical Supplies Act
Lower Premiums, Faster Payments Act
More bills from Sen. Cassidy, Bill [R-LA]
Domestic Manufacturing Revitalization Act of 2026
Taxpayer Funded Compensation Accountability Act
Safe and Fair Elections Act of 2026
A bill to amend the Internal Revenue Code of 1986 to increase the qualified elementary and secondary education scholarships credit limit for married taxpayers filing a joint return.
Bill100 mirrors the public U.S. legislative record from Congress.gov and GovTrack and adds plain-English AI summaries. It is an information tool, not legal, compliance or lobbying advice, and it is not affiliated with the U.S. Congress or any government agency. AI summaries can simplify or omit detail — every bill links to the official source; verify there before you rely on it.